Soo In Hwang
Fundador en VINCERX PHARMA, INC. .
Perfil
Soo In Hwang is the founder.
In 2018, Dr. Hwang founded Vincerx Pharma, Inc. as the Chief Business Officer.
Dr. Hwang is also the founder of Vincera Pharma, Inc. Dr. Hwang's former job(s) include being a Managing Director at Mavericks Capital LLC from 2014 to 2016, a Founding Scientist at Celera Group, a Chief Business Officer at Quadriga BioSciences, Inc. from 2014 to 2016, and the President of Digestome Therapeutics, Inc. Dr. Hwang was also a Managing Partner at Third Pillar Associates LLC.
Dr. Hwang's education history includes a doctorate degree from the University of California, Berkeley and an undergraduate degree from the University of California, Santa Cruz.
Cargos activos de Soo In Hwang
| Empresas | Cargo | Inicio |
|---|---|---|
| VINCERX PHARMA, INC. | Fundador | 19/12/2018 |
Antiguos cargos conocidos de Soo In Hwang.
| Empresas | Cargo | Fin |
|---|---|---|
Quadriga BioSciences, Inc.
 Quadriga BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Quadriga BioSciences, Inc. is a privately held pharmaceutical company based in an undisclosed location. The American company is focused on developing proprietary targeted cancer therapies by exploiting the biology of aggressive forms of cancer cells that over-express certain unique amino acid transporters on their cell surfaces. The company's mission is to develop safer and more effective treatments for patients with cancer. The company was founded by Bernd Jandeleit, Kerry J. Koller, and Wolf-Nicolas Fischer. Gordon Ringold has been the CEO of the company since 2015. | Corporate Officer/Principal | 01/12/2016 |
| Mavericks Capital LLC | Corporate Officer/Principal | 01/09/2016 |
Celera Group
 Celera Group Pharmaceuticals: MajorHealth Technology Celera Group provides molecular diagnostics using proprietary genomics and proteomics discovery platforms to identify and validate novel diagnostic markers and to develop diagnostic products based on these markers. These diagnostic products are used to predict disease risk and optimize therapy selection, monitoring and patient outcome. The company was founded in May, 1998 and is located in Rockville, MD | Corporate Officer/Principal | - |
| Third Pillar Associates LLC | Corporate Officer/Principal | - |
Digestome Therapeutics, Inc.
 Digestome Therapeutics, Inc. Medical/Nursing ServicesHealth Services Digestome Therapeutics, Inc. is a company that focuses on developing sar-optimized drug candidates for various conditions such as depression, anxiety, inflammatory disease, and tinnitus. The company is based in San Francisco, CA. The company's drug candidates are gut-acting and gut-restricted, which provides a safer profile compared to most approved psychiatric drugs. The company was founded in 2018 by Kousaku Ohinata, and the CEO is Kenneth Nicholas Horne. | Presidente | - |
Formación de Soo In Hwang.
| University of California, Berkeley | Doctorate Degree |
| University of California, Santa Cruz | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| VINCERX PHARMA, INC. | Health Technology |
| Empresas privadas | 6 |
|---|---|
Vincera Pharma, Inc. /Old/
 Vincera Pharma, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Vincera Pharma, Inc. operates as a biopharmaceutical company. It develops and delivers medicines to patients. The company was founded by Ahmed Hamdy, Raquel Izumi, Tom Thomas, Stuart Hwang, and John Byrd and is headquartered in Santa Clara, CA. | Health Technology |
Digestome Therapeutics, Inc.
Digestome Therapeutics, Inc. Medical/Nursing ServicesHealth Services Digestome Therapeutics, Inc. is a company that focuses on developing sar-optimized drug candidates for various conditions such as depression, anxiety, inflammatory disease, and tinnitus. The company is based in San Francisco, CA. The company's drug candidates are gut-acting and gut-restricted, which provides a safer profile compared to most approved psychiatric drugs. The company was founded in 2018 by Kousaku Ohinata, and the CEO is Kenneth Nicholas Horne. | Health Services |
| Third Pillar Associates LLC | |
Quadriga BioSciences, Inc.
Quadriga BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Quadriga BioSciences, Inc. is a privately held pharmaceutical company based in an undisclosed location. The American company is focused on developing proprietary targeted cancer therapies by exploiting the biology of aggressive forms of cancer cells that over-express certain unique amino acid transporters on their cell surfaces. The company's mission is to develop safer and more effective treatments for patients with cancer. The company was founded by Bernd Jandeleit, Kerry J. Koller, and Wolf-Nicolas Fischer. Gordon Ringold has been the CEO of the company since 2015. | Health Technology |
| Mavericks Capital LLC | |
Celera Group
Celera Group Pharmaceuticals: MajorHealth Technology Celera Group provides molecular diagnostics using proprietary genomics and proteomics discovery platforms to identify and validate novel diagnostic markers and to develop diagnostic products based on these markers. These diagnostic products are used to predict disease risk and optimize therapy selection, monitoring and patient outcome. The company was founded in May, 1998 and is located in Rockville, MD | Health Technology |
- Bolsa de valores
- Insiders
- Soo In Hwang
